Preventive Conditioned NIV Therapy after planned extubation
DeviceConditioned NIV during 48 hours following extubation.
NCT Number: NCT04125342
The main aim is to demonstrate whether reintubation rate is lower with preventive conditioned noninvasive ventilation (NIV) rather than with High-flow oxygen therapy (HFOT) in obese intermediate-risk patients and in high-risk patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Hospital Virgen de la Salud, Toledo, Castille-La Mancha, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Conditioned NIV during 48 hours following extubation.
HFOT set according to patients tolerance during 48 hours following extubation
Time frame: 7 days
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 6 months
Time frame: 6 months
Hospital Virgen de la Salud
Other
Effect of Postextubation High-Flow Nasal Cannula vs Noninvasive Ventilation on Reintubation in Obese or High-Risk Patients. A Randomized Clinical Trial.
Acronym: HINFOR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07664085
Acute Brain Injury, Brain Diseases
Hanoi, Vietnam
View Trial DetailsNCT05637099
Extubation Failure, Mechanical Ventilation
Rotterdam, South Holland, Netherlands
View Trial DetailsNCT07630766
Extubation Failure
Banhā, Qalyubia Governorate, Egypt
View Trial DetailsNCT07038291
Extubation Failure, Ventilated Patients
Jakarta Pusat, DKI Jakarta, Indonesia
View Trial Details